HIV-1 as RNA evolution machine

RNA Biology

Volumn 8, Issue 2, 2011, Pages

  Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Mutation; Recombination; Riboswitch; RNA structure and function; Selection; SELEX; Virus evolution

Indexed keywords

RNA; TRANSFER RNA; VIRUS RNA;

ANALYTIC METHOD; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYADENYLATION; REVIEW; RNA INTERFERENCE; RNA SPLICING; RNA STRUCTURE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79954477251     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/hv.8.2.14801     Document Type: Review

References (83)

1. Bebenek K, Abbotts J, Roberts JD, Wilson SH, Kunkel TA. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 1989; 264:16948-56. (Pubitemid 19243600)
2. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH. Nature, position and frequency of mutations made in a single cycle of HIV-1 replication. J Virol 2010; 84:9864-78.
3. Berkhout B, de Ronde A. APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations. AIDS 2004; 18:1861-3. (Pubitemid 39179645)
4. Pillai SK, Wong JK, Barbour JD. Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology 2008; 5:26.
5. Wood N, et al. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 2009; 5:1000414.
6. Konstantinova P, de Haan P, Das AT, Berkhout B. Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1. Nucleic Acids Res 2006; 34:2206-18. (Pubitemid 43985659)
7. Berkhout B, Verhoef K, van Wamel JL, Back NK. Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J Virol 1999; 73:1138-45. (Pubitemid 29036765)
8. Marzio G, Verhoef K, Vink M, Berkhout B. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci USA 2001; 98:6342-7.
9. Berkhout B, Das AT, Beerens N. HIV-1 RNA editing, hypermutation and error-prone reverse transcription. Science 2001; 292:7.
10. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 1995; 267:483-9.
11. Keulen W, Boucher C, Berkhout B. Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res 1996; 31:45-57. (Pubitemid 26184459)
12. Lacey SF, Larder BA. Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance. J Virol 1994; 5:3421-4. (Pubitemid 24129796)
13. Berkhout B, Das AT. Virus evolution as a tool to study HIV-1 biology. Methods Mol Biol 2009; 485:436-51.
14. Klaver B, Berkhout B. Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J Virol 1994; 68:3830-40.
15. Hache G, Shindo K, Albin JS, Harris RS. Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Curr Biol 2008; 18:819-24.
16. Hache G, Abbink TE, Berkhout B, Harris RS. Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G. J Virol 2009; 83:5956-60.
17. Berkhout B. A new Houdini act: multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiology 2009; 4:151-4.
18. Leonard JN, Shah PS, Burnett JC, Schaffer DV. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 2008; 4:484-94.
19. Keulen W, Back NKT, van Wijk A, Boucher CAB, Berkhout B. Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of the human immunodeficiency virus type 1 Reverse Transcriptase. J Virol 1997; 71:3346-50. (Pubitemid 27121581)
20. Breaker RR. Natural and engineered nucleic acids as tools to explore biology. Nature 2004; 432:838-45. (Pubitemid 40037139)
21. Berkhout B, Klaver B. In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res 1993; 21:5020-4.
22. Morris S, Johnson M, Stavnezer E, Leis J. Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J Virol 2002; 76:7571-7. (Pubitemid 34760980)
23. Doria-Rose NA, Vogt VM. In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal. J Virol 1998; 72:8073-82.
24. Rieger A, Nassal M. Distinct requirements for primary sequence in the 5′- and 3′-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combination in vivo selection/in vitro amplification system. Nucleic Acids Res 1995; 23:3909-15.
25. Sun X, Zhang G, Simon AE. Short internal sequences involved in replication and virion accumulation in a subviral RNA of turnip crinkle virus. J Virol 2005; 79:512-24. (Pubitemid 39648404)
26. Zhang J, Simon AE. Importance of sequence and structural elements within a viral replication repressor. Virol 2005; 333:301-15. (Pubitemid 40250114)
27. Yoon M, Spear PG. Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. Proc Natl Acad Sci USA 2004; 101:17252-7. (Pubitemid 39627806)
28. Verhoef K, Marzio G, Hillen W, Bujard H, Berkhout B. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat J Virol 2001; 75:979-87. (Pubitemid 32037300)
29. Marzio G, Vink M, Verhoef K, de Ronde A, Berkhout B. Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. J Virol 2002; 76:3084-8. (Pubitemid 34184897)
30. Das AT, et al. Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J Biol Chem 2004; 279:18776-82. (Pubitemid 38623303)
31. Zhou X, Vink M, Klaver B, Berkhout B, Das AT. Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther 2006; 13:1382-90. (Pubitemid 44420633)
32. Zhou X, et al. Improved single-chain transactivators of the Tet-On gene expression system. BMC Biotechnol 2007; 7:6.
33. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol 1996; 54:1-34.
34. Ooms M, Verhoef K, Southern E, Huthoff H, Berkhout B. Probing alternative foldings of the HIV-1 leader RNA by antisense oligonucleotide scanning arrays. Nucleic Acids Res 2004; 32:819-27. (Pubitemid 38263075)
35. Huthoff H, Berkhout B. Two alternating structures for the HIV-1 leader RNA. RNA 2001; 7:143-57. (Pubitemid 32381937)
36. Huthoff H, Berkhout B. Multiple secondary structure rearrangements during HIV-1 RNA dimerization. Biochem 2002; 41:10439-45.
37. Berkhout B, van Wamel JL. The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA 2000; 6:282-95. (Pubitemid 30091598)
38. Ooms M, Huthoff H, Russell R, Liang C, Berkhout B. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol 2004; 78:10814-9. (Pubitemid 39258406)
39. Berkhout B, et al. In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes. J Biol Chem 2002; 277:19967-75.
40. Abbink TEM, Ooms M, Haasnoot PCJ, Berkhout B. The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochem 2005; 44:9058-66. (Pubitemid 40943220)
41. Watts JM, et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009; 460:711-6.
42. Wilkinson KA, et al. High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol 2008; 6:96.
43. Paillart JC, et al. First snapshots of the HIV-1 RNA structure in infected cells and in virions. J Biol Chem 2004; 279:48397-403.
44. Ooms M, Abbink TE, Pham C, Berkhout B. Circularization of the HIV-1 RNA genome. Nucleic Acids Res 2007; 35:5253-61. (Pubitemid 47394208)
45. Beerens N, Kjems J. Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription. RNA 2010; 16:1226-35.
46. Klaver B, Berkhout B. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J 1994; 13:2650-9. (Pubitemid 24188398)
47. Vrolijk MM, Harwig A, Berkhout B, Das AT. Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation. Retrovirology 2009; 6:13.
48. Vrolijk MM, Ooms M, Harwig A, Das AT, Berkhout B. Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res 2008; 36:4352-63.
49. Das AT, Klaver B, Berkhout B. A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol 1999; 73:81-91. (Pubitemid 28565349)
50. Klasens BIF, Das AT, Berkhout B. Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res 1998; 26:1870-6. (Pubitemid 28291718)
51. Klasens BIF, Thiesen M, Virtanen A, Berkhout B. The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res 1999; 27:446-54. (Pubitemid 29210007)
52. Das AT, Klaver B, Klasens BIF, van Wamel JLB, Berkhout B. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol 1997; 71:2346-56. (Pubitemid 27078617)
53. Berkhout B, Klaver B, Das AT. Forced evolution of a regulatory RNA helix in the HIV-1 genome. Nucleic Acids Res 1997; 25:940-7. (Pubitemid 27298261)
54. Gilmartin GM, Fleming ES, Oetjen J. Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR. EMBO J 1992; 11:4419-28.
55. Gilmartin GM, Fleming ES, Oetjen J, Graveley BR. CPSF recognition of an HIV-1 mRNA 3′-processing enhancer: multiple sequence contacts involved in poly(A) site definition. Genes Dev 1995; 9:72-83.
56. Valsamakis A, Schek N, Alwine JC. Elements upstream of the AAU AAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro. Mol Cell Biol 1992; 12:3699-705.
57. Valsamakis A, Zeichner S, Carswell S, Alwine JC. The human immunodeficiency virus type 1 polyadenylylation signal: a 3′ long terminal repeat element upstream of the AAU AAA necessary for efficient polyadenylylation. Proc Natl Acad Sci USA 1991; 88:2108-12. (Pubitemid 21916363)
58. Weichs an der Glon C, Monks J, Proudfoot NJ. Occlusion of the HIV poly(A) site. Genes Dev 1991; 5:244-53.
59. Weichs an der Glon C, Ashe M, Eggermont J, Proudfoot NJ. Tat-dependent occlusion of the HIV poly(A) site. EMBO J 1993; 12:2119-28.
60. Ashe MP, Griffin P, James W, Proudfoot NJ. Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev 1995; 9:3008-25.
61. Ashe MP, Furger A, Proudfoot NJ. Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation. RNA 2000; 6:170-7. (Pubitemid 30091588)
62. Purcell DFJ, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication and infectivity. J Virol 1993; 67:6365-78. (Pubitemid 23309100)
63. Damgaard CK, Tange TO, Kjems J. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA 2002; 8:1401-15. (Pubitemid 35332964)
64. Zahler AM, Damgaard CK, Kjems J, Caputi M. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. J Biol Chem 2004; 279:10077-84. (Pubitemid 38372611)
65. Si Z, Amendt BA, Stoltzfus CM. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res 1997; 25:861-7. (Pubitemid 27299844)
66. Amendt BA, Si ZH, Stoltzfus CM. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: Evidence for inhibition mediated by cellular factors. Mol Cell Biol 1995; 15:4606-15.
67. Abbink TE, Berkhout B. RNA structure modulates splicing efficiency at the HIV-1 major splice donor. J Virol 2007; 82:3090-8. (Pubitemid 351329197)
68. Konstantinova P, Ter Brake O, Haasnoot J, de Haan P, Berkhout B. Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome. Retrovirology 2007; 4:15.
69. Beerens N, Groot F, Berkhout B. Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription. Nucleic Acids Res 2000; 28:4130-7.
70. Kleiman L. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1. IUBMB. Life 2002; 53:107-14.
71. Abbink TE, Berkhout B. HIV-1 reverse transcription initiation: a potential target for novel antivirals? Virus Res 2008; 134:4-18.
72. Marquet R, Isel C, Ehresmann C, Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie 1995; 77:113-24.
73. Das AT, Klaver B, Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol 1995; 69:3090-7.
74. Lys3. J Virol 1995; 69:6021-9.
75. Abbink TEM, Beerens N, Berkhout B. Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme. J Virol 2004; 78:10706-14. (Pubitemid 39258396)
76. van der Hoek L, et al. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase. J Virol 2005; 79:3536-43.
77. Takebe Y, Telesnitsky A. Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virol 2006; 351:1-6. (Pubitemid 44037669)
78. Das AT, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004; 78:2601-5. (Pubitemid 38228957)
79. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005; 33:796-804. (Pubitemid 40361009)
80. Westerhout EM, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA interference. Nucleic Acids Res 2007; 35:4322-30. (Pubitemid 47244586)
81. Licis N, Balklava Z, van Duin J. Forced retroevolution of an RNA bacteriophage. Virol 2000; 271:298-306. (Pubitemid 30461308)
82. Klovins J, Tsareva NA, de Smit MH, Berzins V, van Duin J. Rapid evolution of translational control mechanisms in RNA genomes. J Mol Biol 1997; 265:372-84. (Pubitemid 27110674)
83. Olsthoorn RCL, van Duin J. Evolutionary reconstruction of a hairpin deleted from the genome of an RNA virus. Proc Natl Acad Sci USA 1996; 93:12256-61 (Pubitemid 26367129)